U.S. Markets open in 5 hrs 8 mins
  • S&P Futures

    4,257.00
    +1.00 (+0.02%)
     
  • Dow Futures

    34,146.00
    +64.00 (+0.19%)
     
  • Nasdaq Futures

    14,359.50
    +5.25 (+0.04%)
     
  • Russell 2000 Futures

    2,331.80
    +0.60 (+0.03%)
     
  • Crude Oil

    73.44
    +0.14 (+0.19%)
     
  • Gold

    1,782.00
    +5.30 (+0.30%)
     
  • Silver

    26.26
    +0.21 (+0.81%)
     
  • EUR/USD

    1.1953
    +0.0019 (+0.1554%)
     
  • 10-Yr Bond

    1.4870
    0.0000 (0.00%)
     
  • Vix

    16.11
    -0.21 (-1.29%)
     
  • GBP/USD

    1.3911
    -0.0010 (-0.0751%)
     
  • USD/JPY

    110.7350
    -0.1000 (-0.0902%)
     
  • BTC-USD

    33,987.87
    +869.77 (+2.63%)
     
  • CMC Crypto 200

    814.41
    +27.79 (+3.53%)
     
  • FTSE 100

    7,117.14
    +7.17 (+0.10%)
     
  • Nikkei 225

    29,066.18
    +190.95 (+0.66%)
     

Singapore approves COVID-19 vaccine for use in 12 to 15-year-olds

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

SINGAPORE, May 18 (Reuters) - Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years old in a bid to extend protection to more groups as the country tackles a recent increase of infections, officials said on Tuesday.

"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding "its safety profile is also consistent with the known safety profile in the adult population".

The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.

(Reporting by Chen Lin in Singapore Editing by Ed Davies)